Zuo Li, Wang Mei
Department of Medicine, Renal Division, Peking University First Hospital , Beijing, China ; Institute of Nephrology, Peking University , Beijing, China ; Key Laboratory of Renal Disease, Ministry of Health of China , Beijing, China.
Department of Nephrology, Peking University People's Hospital , Beijing, China.
Kidney Int Suppl (2011). 2013 May;3(2):167-169. doi: 10.1038/kisup.2013.6.
The Beijing Hemodialysis Quality Control and Improvement Center started patient data collection from 2007. We report here the trends in incidence, prevalence, and mortality of end-stage renal disease (ESRD) patients on maintenance hemodialysis (MHD). The incidence increased from 94 per million population in 2007 to 147.3 per million population in 2010. The leading cause of ESRD changed from chronic glomerulonephritis (32.1%) to diabetes (40.1%). The point prevalence of MHD at the end of 2006 was 269 per million population, and gradually increased to 509 per million population in the end of 2010. The leading cause of ESRD in 2010 prevalent patients was chronic nephritis (33.9%), followed by diabetes (29.5%). The annual mortality varied from 7.4 to 9.0%. Old or diabetic patients suffered a higher mortality. The 2010 prevalent MHD patients achieved KDOQI hemoglobin, calcium, phosphate, and intact parathyroid hormone guidelines, which was comparable to other DOPPS (Dialysis Outcome and Practice Pattern Study) countries; Beijing MHD patients had a relatively higher albumin level.
北京血液透析质量控制与改进中心自2007年开始收集患者数据。我们在此报告维持性血液透析（MHD）的终末期肾病（ESRD）患者的发病率、患病率及死亡率趋势。发病率从2007年的每百万人口94例增至2010年的每百万人口147.3例。ESRD的主要病因从慢性肾小球肾炎（32.1%）转变为糖尿病（40.1%）。2006年末MHD的点患病率为每百万人口269例，并于2010年末逐渐增至每百万人口509例。2010年患病患者中ESRD的主要病因是慢性肾炎（33.9%），其次是糖尿病（29.5%）。年死亡率在7.4%至9.0%之间。老年患者或糖尿病患者死亡率更高。2010年的MHD患病患者达到了美国肾脏病基金会改善全球肾脏病预后组织（KDOQI）的血红蛋白、钙、磷及全段甲状旁腺激素指南要求，这与其他透析预后与实践模式研究（DOPPS）国家相当；北京MHD患者的白蛋白水平相对较高。
